Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the formation of a scientific advisory board in major depressive disorder.
Rexahn Pharmaceuticals announces formation of scientific advisory Board in major depressive disorder